Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 15, Pages -Publisher
MDPI
DOI: 10.3390/ijms22158272
Keywords
primary ciliary dyskinesia; molecular genetics; genotype-phenotype association
Funding
- National Institutes of Health (NIH) [HL096458, HL116211, HL125241, AI46999]
- National Health and Medical Research Council [NHMRC1043768]
- Parion Sciences
- Aerocrine Pharmaceuticals
- National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network (RDCRN) [U54HL096458]
- RDCRN Data Management and Coordinating Center (DMCC) [U2CTR002818]
- NCATS
- National Heart, Lung, and Blood Institute (NHLBI)
Ask authors/readers for more resources
PCD is a rare inherited condition affecting motile cilia and leading to organ laterality defects, recurrent infections, bronchiectasis, and severe lung disease. Research has shown variability in clinical presentations and relationships between genotype and phenotype. Advancements in genetic testing continue to redefine these relationships and uncover previously unrecognized milder forms of the disease.
Primary ciliary dyskinesia (PCD) is a rare inherited condition affecting motile cilia and leading to organ laterality defects, recurrent sino-pulmonary infections, bronchiectasis, and severe lung disease. Research over the past twenty years has revealed variability in clinical presentations, ranging from mild to more severe phenotypes. Genotype and phenotype relationships have emerged. The increasing availability of genetic panels for PCD continue to redefine these genotype-phenotype relationships and reveal milder forms of disease that had previously gone unrecognized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available